News Break! Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.

Press releases published on November 3, 2026

Nov. 3, 2026

Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Septerna to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Oryzon announces authorization in Spain of VIVALDI, a collaborative clinical study with CETLAM to evaluate iadademstat in combination with standard-of-care therapy in high-risk newly-diagnosed AML subpopulations

Indeterminate GlobeNewswire

Nov. 3, 2026

Global-e to Announce Financial Results for the Third Quarter 2026 on November 18, 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

Ardelyx Completes Enrollment in Phase 3 ACCEL Clinical Trial of IBSRELA® (tenapanor) in Adults with Chronic Idiopathic Constipation

Indeterminate GlobeNewswire

Nov. 3, 2026

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 3, 2026

One Bullion Reports Significant Historical Gold Results and Advances Exploration at Vumba

Indeterminate GlobeNewswire

Nov. 3, 2026

TurboGen Completes Assembly of First TR2000 20kW Combined Heat and Power System for Use in Defense and Civilian Markets

Indeterminate GlobeNewswire

Nov. 3, 2026

Kailera Therapeutics to Participate in November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Nexera Technologies: Subsidiary Fort Technology Announces Receipt of Approval for a Voluntary Delisting of its Common Shares From the TSX Venture Exchange

Indeterminate GlobeNewswire

Nov. 3, 2026

Why Fat Transfer Breast Enlargement Is Trending in Dubai

Indeterminate GlobeNewswire

Nov. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 3, 2026

MitoRx Therapeutics Appoints Neil Anderson as Chief Business Officer

Indeterminate GlobeNewswire

Nov. 3, 2026

Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire

Nov. 3, 2026

Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion

Indeterminate GlobeNewswire

Nov. 3, 2026

Maze Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Parabilis Medicines to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire

Nov. 3, 2026

Tango Therapeutics to Participate in Guggenheim’s 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 3, 2026

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire